Rationale: (+/-) 3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") has
been shown to cause long term damage to serotonergic cerebral neurons in an
imals. The neurotoxic effects in humans are less clear and little is known
about the functional consequences, although some studies suggest memory imp
airment. Given the widespread use of MDMA, our lack of knowledge raises con
cerns. Objective: We investigated, in humans, the relation between past use
of ecstasy and cognitive performance as well as serotonergic function. Met
hods: Two groups of 21 males with moderate and heavy recreational use of MD
MA, respectively, and a control group of 20 males without use of MDMA were
compared. All were from the same subculture. Reaction time, direct recall,
and recognition were assessed. Serotonergic function was measured by the ne
uro-endocrine response to a placebo-controlled, crossover challenge with de
xfenfluramine. Results: Ecstasy users showed a broad pattern of statistical
ly significant, but clinically small, impairment of memory and prolonged re
action times. Heavy users were affected stronger than moderate users. Relea
se of cortisol but not of prolactin after dexfenfluramine administration wa
s significantly reduced in both groups of ecstasy users compared with the c
ontrols, Analyses of covariance showed that likely confounding variables in
cluding recent exposure to ecstasy, psychosocial profiles and use of other
drugs did not explain the differences found between the groups. Conclusions
: These results provide further evidence that use of ecstasy may be associa
ted with impairment of memory and of serotonergic function. These findings
are compatible with neurotoxicity of ecstasy as shown in animals.